Oncology & Cancer

Low-dose sorafenib may improve therapy for head and neck cancer

Adding low doses of the targeted agent sorafenib to the chemotherapy and radiation now often used to treat head and neck cancer might significantly improve patient care and quality of life, according to a new study by researchers ...

Oncology & Cancer

Consumer Health: 4 types of head and neck cancers

Head and neck cancers account for nearly 4% of all cancers in the U.S., according to the National Cancer Institute. These cancers are more than twice as common among men as women, and are diagnosed more often among people ...

page 13 from 19